Ac-LKKTETQ is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-04-08. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
| Property | Value | Notes |
|---|---|---|
| Reported sequence | Ac-LKKTETQ | Described in most listings as the actin-binding region of thymosin beta-4 |
| Reported molecular weight | Approximately 889 Da | Value shifts with the stated sequence; compare against the certificate of analysis |
| Parent protein length | 43 amino acids | Thymosin beta-4; the fragment covers only a small part of it |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Trade-style names rather than formal nomenclature |
| Formal monographs | Not established | Labeling conventions differ by supplier and region |
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
=== Uhlenhuth test === The Uhlenhuth test, or the antigen–antibody precipitin test for species, was invented by Paul Uhlenhuth in 1901 and could distinguish human blood from animal blood, based on the discovery that the blood of different species had one or more characteristic proteins. The test represented a major breakthrough and came to have tremendous importance in forensic science. The test was further refined for forensic use by the Swiss chemist Maurice Müller in the year 1960s.
Viktor Antonov was born in Sofia, Bulgaria, on 5 February 1972. He later stated his lifelong passion for architecture and worldbuilding—the creation of detailed fictional worlds—originated from his childhood living in Sofia whilst Bulgaria was a socialist state politically aligned with the Soviet Union. The country's poor economy meant large areas of the city were typically empty, letting him easily break into buildings and engage in "urban exploration" inside them; this gave him an appreciation of their designs. Antonov moved to Paris at age 17, and then to Los Angeles some time later. He engaged in "very rigorous" studies of design at the ArtCenter College of Design in Pasadena, California, later saying it was "one of the harshest schools there are". He received a degree in transportation design, and started working as an architect of concept cars. He also worked in TV commercial production, planning to enter the special effects industry in L.A. However, Antonov decided to follow video game design after getting a job at local developer Xatrix Entertainment (now Gray Matter Interactive).
== Notable researchers == Roger Guillemin and Andrew W. Schally were awarded the Nobel Prize in Physiology and Medicine in 1977 for their contributions to understanding "the peptide hormone production of the brain"; these scientists independently first isolated TRH and GnRH and then identified their structures.
Sources: en.wikipedia.org
18,174 – October 2013, Digital Citizens Alliance, 13,472 of which were on Silk Road in November 2013 41,207 – April 2014 Digital Citizens Alliance 33,985 – May 2014 The Guardian via Reddit 43,175 – July 2014 a report by the BBC 65,595 – August 2014 Digital Citizens Alliance 51,755 – December 2014 Digital Citizens Alliance 68,835 – March 2015 (before Evolution scam), Digital Citizens Alliance 68,322 – April 2015 (after Evolution scam) Digital Citizens Alliance
The study of catalysis and catalytic reactions is very important to the field of physical organic chemistry. A catalyst participates in the chemical reaction but is not consumed in the process. A catalyst lowers the activation energy barrier (ΔG‡), increasing the rate of a reaction by either stabilizing the transition state structure or destabilizing a key reaction intermediate, and as only a small amount of catalyst is required it can provide economic access to otherwise expensive or difficult to synthesize organic molecules. Catalysts may also influence a reaction rate by changing the mechanism of the reaction.
==== Supermarkets ==== The third and final change to US food distribution in the first half of the 20th century involved the establishment of supermarkets. The Ford Motor Company performed the first experiment regarding the profitability of large-scale supermarkets after the end of World War I. Supermarkets officially began gaining prominence in the 1930s and steadily continued their growth into the post-WWII era.
Sources: en.wikipedia.org
rescue The restoration of a defective cell or tissue to a healthy or normal condition, or the reversion or recovery of a mutant gene to its normal functionality, especially in the context of experimental genetics, where an experiment (e.g. a drug, cross, or gene transfer) resulting in such a restoration is said to rescue the normal phenotype.
If n and m are too small, the structure described by the pair (n,m) will describe a molecule that cannot be reasonably called a "tube", and may not even be stable. For example, the structure theoretically described by the pair (1,0) (the limiting "zigzag" type) would be just a chain of carbons. That is a real molecule, the carbyne; which has some characteristics of nanotubes (such as orbital hybridization, high tensile strength, etc.) — but has no hollow space, and may not be obtainable as a condensed phase. The pair (2,0) would theoretically yield a chain of fused 4-cycles; and (1,1), the limiting "armchair" structure, would yield a chain of bi-connected 4-rings. These structures may not be realizable. The thinnest carbon nanotube proper is the armchair structure with type (2,2), which has a diameter of 0.3 nm. This nanotube was grown inside a multi-walled carbon nanotube. Assigning of the carbon nanotube type was done by a combination of high-resolution transmission electron microscopy (HRTEM), Raman spectroscopy, and density functional theory (DFT) calculations. The thinnest freestanding single-walled carbon nanotube is about 0.43 nm in diameter. Researchers suggested that it can be either (5,1) or (4,2) SWCNT, but the exact type of the carbon nanotube remains questionable. (3,3), (4,3), and (5,1) carbon nanotubes (all about 0.4 nm in diameter) were unambiguously identified using aberration-corrected high-resolution transmission electron microscopy inside double-walled CNTs.
=== Fish === A University of Florida scientist reports that male sand gobies work harder at building nests and taking care of eggs when females are present – the first time such "courtship parental care" has been documented in any species. In the cichlid species Tropheus moorii, a male and female will form a temporary monogamous pair bond and spawn; after which, the female leaves to mouthbrood the eggs on her own. T. moorii broods exhibit genetic monogamy (all eggs in a brood are fertilized by a single male). Another mouth brooding cichlid – the Lake Tanganyika cichlid (Xenotilapia rotundiventralis) has been shown that mating pairs maintain pair bonds at least until the shift of young from female to male. More recently the Australian Murray cod has been seen maintaining pair bonds over 3 years. Pair bonding may also have non-reproductive benefits, such as assisted resource defense. Recent study comparing two species of butterflyfishes, C. baronessa and C. lunulatus, indicate increase in food and energy reserves compared to individual fish.
Therefore, while the electronic placement of hydrogen in group 1 predominates, some rarer arrangements show either hydrogen in group 17, duplicate hydrogen in both groups 1 and 17, or float it separately from all groups. This last option has nonetheless been criticized by the chemist and philosopher of science Eric Scerri on the grounds that it appears to imply that hydrogen is above the periodic law altogether, unlike all the other elements. Helium is the only element that routinely occupies a position in the periodic table that is not consistent with its electronic structure. It has two electrons in its outermost shell, whereas the other noble gases have eight; and it is an s-block element, whereas all other noble gases are p-block elements. However it is unreactive at standard conditions, and has a full outer shell: these properties are like the noble gases in group 18, but not at all like the reactive alkaline earth metals of group 2. For these reasons helium is nearly universally placed in group 18 which its properties best match; a proposal to move helium to group 2 was rejected by IUPAC in 1988 for these reasons. Nonetheless, helium is still occasionally placed in group 2 today, and some of its physical and chemical properties are closer to the group 2 elements and support the electronic placement. Solid helium crystallises in a hexagonal close-packed structure, which matches beryllium and magnesium in group 2, but not the other noble gases in group 18.
Sources: en.wikipedia.org
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.
No. Thymosin beta-4 is a protein of 43 amino acids, while TB-500 is described as a short fragment of it. The two differ in size, structure, and the range of interactions each can support.
Naming for research peptides is not centrally coordinated, so vendors set their own labels and specifications. Differences in stated sequence, molecular weight, or purity documentation usually trace back to those independent labeling choices.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.